If you are weighing ketamine therapy in Sandy, UT for chronic pain, you deserve a clear-eyed look at what the research actually supports before you book. That means being honest about which conditions respond, how durable the relief tends to be, and who is not a candidate. As an integrative practice, that honesty is where we prefer to begin.
What the Research Actually Shows
Ketamine for chronic pain is promising and incomplete, and you deserve both halves of that sentence before you book.
The evidence is not equally strong across the conditions we treat, and we would rather tell you where your diagnosis sits than let a website imply more certainty than exists.
Complex regional pain syndrome has the strongest support. Randomized trials show clear pain reduction immediately following an infusion series. The honest limitation is durability, because in most studies the advantage over placebo was no longer statistically significant by around the twelve week mark.
Neuropathic pain has moderate support. Pooled analyses of randomized trials found measurable reductions in pain intensity at one week that were still detectable at thirty days. In one pooled analysis, roughly half of ketamine-treated patients met the threshold for a meaningful response, compared with about one in five on placebo. Researchers rated the certainty of that evidence as low, largely because dosing and study populations varied so widely.
Fibromyalgia has the weakest and least consistent support. Patients frequently report relief during and shortly after an infusion, but several trials found no significant difference from placebo at follow-up.
A 2025 Cochrane review concluded there was no clear evidence of benefit for chronic non-cancer, non-headache pain once studies with trustworthiness concerns were excluded. We mention it because you should be able to find it on our site rather than somewhere else after you have already paid.
None of this means ketamine will not help you. It means the honest framing is a carefully monitored trial with a defined endpoint, not a treatment anyone can promise will work.
Why Infusion Length Matters
Treating pain is different than depression, a single protocol built for depression, delivered over roughly forty minutes may not be your best odds for improvement with pain management. It is well established for mood, and many clinics apply it to pain patients because it is the protocol already in the building.
The chronic pain literature points elsewhere. Across the consensus guidelines and the trials behind them, the recurring finding is that total cumulative exposure and infusion duration, rather than peak dose, best predict how long relief lasts. Short single infusions often produce relief that fades within hours. The studies showing benefit measured in weeks used longer infusions and repeated sessions.
That is why our chronic pain infusions are built around extended sessions and a treatment series rather than a single short appointment. The consensus guidelines are also candid that no single correct protocol exists, which is exactly why we build the plan around your diagnosis and your response instead of a template.
Who Is Not a Candidate
Ketamine is not appropriate for everyone, and screening is part of the care rather than an obstacle to it. Consensus guidelines identify several contraindications and cautions, including pregnancy, active psychosis, poorly controlled cardiovascular disease, significant liver disease, elevated intracranial or intraocular pressure, and active substance misuse.
Tolerance can also develop with repeated administration, which can shorten the duration of benefit over time. We factor that into how we space treatments and when we recommend pausing.
Because chronic pain infusions run longer than a standard mental health session, we review liver function before starting a series. Sometimes the outcome of a consultation is that we recommend against treatment, and that is a legitimate result.
How We Measure Whether It Is Working
We define success before treatment starts, and we do not define it by pain score alone. We look for a clinically meaningful reduction in pain, improvement in sleep, activity, and work capacity, and any reduction in breakthrough medication use.
A pain score that drops while your function stays flat is not a result worth repeating. As an integrative practice in Sandy, UT, we also look at what else is feeding the pain, whether that is sleep disruption, hormonal shifts, inflammation, or mood, because chronic pain is rarely a single mechanism and treating it as one is why so many patients cycle through partial solutions.
Frequently Asked Questions
Does ketamine cure chronic pain?
No. Ketamine is not curative for any chronic pain condition. The realistic goal is a meaningful reduction in pain and an improvement in daily function for a period of time, which often requires maintenance treatments to sustain.
Which pain conditions respond best?
Complex regional pain syndrome has the strongest evidence, followed by neuropathic pain. Fibromyalgia has the weakest and least consistent results. We will tell you candidly where your diagnosis falls during your consultation, before you commit to a series.
What if it does not work for me?
We reassess after your initial treatments rather than assuming a full series is the right course. If you are not responding, we will say so and discuss other directions, including options within our integrative practice such as low-dose naltrexone, hormone evaluation, or medical cannabis certification.
Book a Ketamine Consultation in Sandy, UT
Chronic pain is rarely a single mechanism, and the honest first step is a conversation about whether ketamine fits your diagnosis and what we would watch for if it does. At Nervana Medical in Sandy, UT, we will walk through the evidence for your condition, the screening, and a plan built around your response rather than a template.